Cochrane Abstracts
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia or endometrial cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hormone Therapy in Postmenopausal Women and Risk of Endometrial Hyperplasia or Endometrial Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Hormone_therapy_in_postmenopausal_women_and_risk_of_endometrial_hyperplasia_or_endometrial_cancer.
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia or endometrial cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Hormone_therapy_in_postmenopausal_women_and_risk_of_endometrial_hyperplasia_or_endometrial_cancer. Accessed January 20, 2026.
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia or endometrial cancer. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Hormone_therapy_in_postmenopausal_women_and_risk_of_endometrial_hyperplasia_or_endometrial_cancer
Hormone Therapy in Postmenopausal Women and Risk of Endometrial Hyperplasia or Endometrial Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Hormone_therapy_in_postmenopausal_women_and_risk_of_endometrial_hyperplasia_or_endometrial_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hormone therapy in postmenopausal women and risk of endometrial hyperplasia or endometrial cancer
ID - 431390
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431390/all/Hormone_therapy_in_postmenopausal_women_and_risk_of_endometrial_hyperplasia_or_endometrial_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
